First-in-Human (FIH) Study of the Fully-Human Kappa-Lambda CD19/CD47 Bispecific Antibody TG-1801 in Patients (pts) with BCell Lymphoma

site-sidebar-layout : default
ast-site-content-layout : default
site-content-style : default
site-sidebar-style : default
theme-transparent-header-meta : default
stick-header-meta : default
Drug Category : Array
Conference Category : Array
Lead Author : Chea C, et al.
Published Date : 11/12/2022
Download Link : https://www.tgtherapeutics.com/wp-content/uploads/2024/04/Chea-C-TG-1801-ASH-2022-Poster-1.pdf
Download Text : Download
Popup Confirmation? :
astra-migrate-meta-layouts : set
Scroll to Top